| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.5 |